Paper39867321
Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition.
Sobral PS and 6 others. RSC Adv, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition. Papers, record 39867321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39867321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28613862 | Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. | J Med Chem | 2017 | https://conductscience.org/library/papers/28613862 | PubMed |
| 2 | 18075579 | Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. | Nature | 2007 | https://conductscience.org/library/papers/18075579 | PubMed |
| 3 | 33938739 | Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. | J Med Chem | 2021 | https://conductscience.org/library/papers/33938739 | PubMed |
| 4 | 33773287 | If small molecules immunotherapy comes, can the prime be far behind? | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33773287 | PubMed |
| 5 | 34103659 | PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy. | Commun Biol | 2021 | https://conductscience.org/library/papers/34103659 | PubMed |
| 6 | 16381955 | DrugBank: a comprehensive resource for in silico drug discovery and exploration. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/16381955 | PubMed |
| 7 | 34055224 | Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. | ACS Med Chem Lett | 2021 | https://conductscience.org/library/papers/34055224 | PubMed |
| 8 | 35696453 | Computational discovery of small drug-like compounds as potential inhibitors of PD-1/PD-L1 interactions. | J Biomol Struct Dyn | 2023 | https://conductscience.org/library/papers/35696453 | PubMed |
| 9 | 35585982 | Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development. | Front Immunol | 2022 | https://conductscience.org/library/papers/35585982 | PubMed |
| 10 | 34769226 | PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769226 | PubMed |
| 11 | 34839997 | Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/34839997 | PubMed |
| 12 | 26400175 | PubChem Substance and Compound databases. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26400175 | PubMed |
| 13 | 34917131 | Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases. | Front Genet | 2021 | https://conductscience.org/library/papers/34917131 | PubMed |
| 14 | 35450381 | Design, Synthesis, and Evaluation of PD-1/PD-L1 Antagonists Bearing a Benzamide Scaffold. | ACS Med Chem Lett | 2022 | https://conductscience.org/library/papers/35450381 | PubMed |
| 15 | 14632445 | Random forest: a classification and regression tool for compound classification and QSAR modeling. | J Chem Inf Comput Sci | 2003 | https://conductscience.org/library/papers/14632445 | PubMed |
| 16 | 34673001 | Targeting cryptic-orthosteric site of PD-L1 for inhibitor identification using structure-guided approach. | Arch Biochem Biophys | 2021 | https://conductscience.org/library/papers/34673001 | PubMed |
| 17 | 34610423 | Design, synthesis, and structure-activity relationship of PD-1/PD-L1 inhibitors with a benzo[d]isoxazole scaffold. | Bioorg Med Chem Lett | 2021 | https://conductscience.org/library/papers/34610423 | PubMed |
| 18 | 30964291 | Discovery of [1,2,4]Triazolo[4,3- a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. | J Med Chem | 2019 | https://conductscience.org/library/papers/30964291 | PubMed |
| 19 | 35629327 | Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35629327 | PubMed |
| 20 | 33619272 | Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1. | Nat Commun | 2021 | https://conductscience.org/library/papers/33619272 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41939482 | Recent advances in drug repurposing for cancer immunomodulation emerging strategies, mechanistic insights, and clinical translation. | Front Oncol | 2026 | https://conductscience.org/library/papers/41939482 | PubMed |
| 40559656 | A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products. | Mar Drugs | 2025 | https://conductscience.org/library/papers/40559656 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39867321
GET https://conductscience.org/api/papers/v1/39867321/references?page=2